Cabot Wealth Management Inc. Increases Position in Chemed Co. (NYSE:CHE)

Cabot Wealth Management Inc. raised its position in Chemed Co. (NYSE:CHE) by 0.9% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 22,961 shares of the company’s stock after purchasing an additional 202 shares during the quarter. Chemed accounts for approximately 1.7% of Cabot Wealth Management Inc.’s portfolio, making the stock its 22nd largest position. Cabot Wealth Management Inc. owned about 0.15% of Chemed worth $13,799,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Rise Advisors LLC purchased a new stake in shares of Chemed during the first quarter worth $26,000. GAMMA Investing LLC increased its position in shares of Chemed by 34.4% during the second quarter. GAMMA Investing LLC now owns 86 shares of the company’s stock worth $47,000 after acquiring an additional 22 shares during the period. American National Bank & Trust purchased a new stake in shares of Chemed during the third quarter worth $61,000. Mather Group LLC. purchased a new stake in shares of Chemed during the first quarter worth $67,000. Finally, EntryPoint Capital LLC increased its holdings in Chemed by 14.0% in the first quarter. EntryPoint Capital LLC now owns 147 shares of the company’s stock valued at $94,000 after buying an additional 18 shares during the last quarter. Hedge funds and other institutional investors own 95.85% of the company’s stock.

Chemed Trading Up 0.3 %

NYSE:CHE traded up $1.70 during trading hours on Tuesday, hitting $601.97. The company’s stock had a trading volume of 56,794 shares, compared to its average volume of 84,020. The stock has a market capitalization of $9.11 billion, a P/E ratio of 32.40, a price-to-earnings-growth ratio of 2.44 and a beta of 0.44. The stock has a fifty day moving average of $581.32 and a 200-day moving average of $571.23. Chemed Co. has a 52-week low of $502.64 and a 52-week high of $654.62.

Chemed (NYSE:CHE) last posted its earnings results on Wednesday, July 24th. The company reported $5.47 EPS for the quarter, missing the consensus estimate of $5.59 by ($0.12). The business had revenue of $595.88 million during the quarter, compared to analysts’ expectations of $599.20 million. Chemed had a net margin of 12.88% and a return on equity of 29.21%. The business’s quarterly revenue was up 7.6% compared to the same quarter last year. During the same period last year, the company earned $4.71 EPS. On average, sell-side analysts forecast that Chemed Co. will post 21.77 earnings per share for the current year.

Chemed Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, August 30th. Shareholders of record on Monday, August 12th were issued a dividend of $0.50 per share. This is a positive change from Chemed’s previous quarterly dividend of $0.40. The ex-dividend date of this dividend was Monday, August 12th. This represents a $2.00 annualized dividend and a dividend yield of 0.33%. Chemed’s dividend payout ratio (DPR) is presently 10.76%.

Insiders Place Their Bets

In other Chemed news, CEO Kevin J. Mcnamara sold 2,000 shares of the firm’s stock in a transaction dated Monday, August 5th. The stock was sold at an average price of $569.63, for a total transaction of $1,139,260.00. Following the transaction, the chief executive officer now owns 105,735 shares of the company’s stock, valued at approximately $60,229,828.05. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. In related news, Director Andrea R. Lindell sold 831 shares of the firm’s stock in a transaction dated Friday, August 16th. The stock was sold at an average price of $571.51, for a total transaction of $474,924.81. Following the transaction, the director now owns 5,725 shares of the company’s stock, valued at $3,271,894.75. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, CEO Kevin J. Mcnamara sold 2,000 shares of the firm’s stock in a transaction dated Monday, August 5th. The stock was sold at an average price of $569.63, for a total value of $1,139,260.00. Following the transaction, the chief executive officer now directly owns 105,735 shares in the company, valued at approximately $60,229,828.05. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 9,144 shares of company stock valued at $5,264,839. 3.32% of the stock is currently owned by insiders.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.